The UK Guide to Retatrutide: How to Take It, and What It Actually Does
Retatrutide is the most powerful weight-loss drug ever tested in a human trial, and it is not one you can legally be prescribed. In the biggest trial yet, 2,339 people took it for 80 weeks and the highest dose produced an average weight loss of 28.3% of body weight - around 70 pounds. A two-year extension reached 30.3%. A separate trial cut knee osteoarthritis pain by 75.8%. It is also unlicensed everywhere, and the MHRA says anyone selling it in the UK is selling it illegally. This guide holds both facts at once: every major trial with the real numbers, the trial dosing protocol in full, side effects by dose, how to protect your muscle, and what to do instead while you wait.
- Price
- £4.99
- Format
- Instant digital download
- Published
Opens the secure checkout in a new tab. Instant access after payment.
What's inside
- Every major trial with the real numbers - TRIUMPH-1 (n=2,339, 80 weeks), TRIUMPH-4 knee osteoarthritis, TRIUMPH-2 diabetes, TRIUMPH-3 cardiovascular disease, and TRANSCEND-T2D-1, the only Phase 3 study peer-reviewed so far.
- The two numbers in every headline: 28.3% average loss counting only people who stayed on treatment, and 25.0% counting everyone who started. The second is the honest one, and almost nobody quotes it.
- The knee osteoarthritis result that is not about weight at all: a 75.8% reduction in WOMAC pain scores against 40.3% on placebo, with 12% of the top-dose group completely pain-free at 68 weeks.
- How the trial dosing actually worked: everyone started at 2 mg and escalated every four weeks to 4, 9 or 12 mg - and why holding a dose for longer is a legitimate move, not failure.
- Side effects by dose, including the figure that tells you more than any headline: 11.3% of the 12 mg group stopped because of them, and 13.5% in the cardiovascular trial.
- Blood sugar and blood pressure: HbA1c down 1.94 percentage points with no severe hypoglycaemia anywhere, systolic blood pressure down 14.0 mmHg, triglycerides down 37%.
- Protecting your muscle, the part most guides skip: without action 25-40% of the loss can be lean mass, with protein and resistance training roughly 5-15%. Your protein number, worked out.
- What the grey market is actually selling you - unverifiable content, unverified sterility, broken cold chain, guesswork dosing, no pharmacovigilance - and the seven-question checklist for walking away.
- Who must not take it, the class risks that apply to every drug in this family, and the emergency warning signs that mean stop and get help.
- What to do instead today: the licensed NHS and private routes that exist right now, the honest 2027-2028 timeline, and the four habits that make medication work better when it arrives.
- The negative result nobody advertises: the cardiovascular outcomes trended favourably but did not reach statistical significance. Where retatrutide is promising and where it is unproven.
- Four printable tools: the one-page evidence summary, a GP appointment checklist with the exact questions to ask, a muscle-protection plan with your weekly tracker, and a grey-market screening sheet.
How you get it
- Pay securely through Payhip, the store that processes every order.
- The download link is emailed to you the moment payment clears.
- A PDF, readable on any phone, tablet or computer.